• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Dental implant maker faces sanctions for destroying evidence in patent infringement case

Dental implant maker faces sanctions for destroying evidence in patent infringement case

November 27, 2013 By Brad Perriello

Dental implant maker faces sanctions for destroying evidence in patent infringement case

Implant Direct Manufacturing will face sanctions for destroying evidence in a patent infringement lawsuit filed by Zest IP Holdings, a federal magistrate judge ruled this week.

Zest sued Implant Direct in March 2010, alleging infringement of 2 patents covering "Dental attachment assembly," trademark infringement, false advertising and unfair competition on the part of Implant Direct, its former distributor, according to court documents.

The lawsuit was prompted by Implant Direct’s plan to clone Zest’s Locator device, which the erstwhile distributor revealed to Zest in the autumn of 2008, according to the documents. Zest told Implant Direct on Oct. 22, 2008, that it considered the products to be infringing knockoffs and planned to filed a patent infringement lawsuit.

That should have triggered a "litigation hold" on all documents and emails from Implant Direct, Zest argued, but the defendant never put such a hold in place, according to the documents. That meant that relevant emails from Implant Direct’s director of design engineering, Ines Aravena, and president & CEO Dr. Gerald Niznick were lost or destroyed, according to the documents.

"Aravena was an independent contractor working for defendants before she became defendants’ employee. She testified at her deposition that she intentionally deleted her emails because she received so many emails and that no one told her not to delete them," according to court records. "Plaintiffs located in 3rd parties’ files Niznick’s email communications to 3rd-party dentists which may be considered evidence of Niznick’s inducing the 3rd-party dentists to infringe on plaintiffs’ patents. Niznick’s emails to the 3rd-party dentists encourage the dentists to combine defendants’ product with plaintiffs’ ‘Locator’ products. It cannot be disputed that Exhibits 11 and 12 once existed in defendants’ electronic files. However, they appear to no longer exist in defendants’ files and defendants have not produced the emails to plaintiffs in this litigation."

Zest asked U.S. Magistrate Judge William Gallo of the U.S. District Court for Southern California to impose a default judgment and an adverse jury instruction against Implant Direct, along with legal costs.

Gallo declined to impose a default judgment, but granted Zest’s motions for an adverse jury instruction and ordered Implant Direct to pony up for legal costs, according to the records.

"Defendants’ conduct with respect to not preserving and destroying discovery materials amounts to gross negligence, but that conduct does not rise to the level of bad faith sufficient to warrant default judgment under the circumstances," Gallo wrote. "Defendants did not take adequate steps to avoid spoliation of evidence after it should have reasonably anticipated this lawsuit and did not issue a litigation hold nor implement nor monitor an adequate document preservation policy.

"As a sanction for defendant’s spoliation of relevant evidence, the court recommends that an adverse inference instruction should be read to the jury," he added. "This recommendation is warranted in light of the degree of defendants’ fault and the degree of prejudice plaintiffs have suffered. Based on defendants’ conscious and/or willful disregard of its obligations, and in the absence of bad faith, the court recommends that the jury be instructed as follows:

‘Defendants failed to prevent the destruction of relevant evidence for plaintiffs’ use in this litigation. The evidence pertains to the design, development, and testing, of defendants’ products and plaintiffs’ claims that defendants induced infringement of plaintiffs’ patents. This failure resulted from defendants’ failure to perform their discovery obligations.

‘You may, if you find appropriate, presume from that destruction, that the evidence destroyed was relevant to plaintiffs’ case and that the destroyed evidence was favorable to plaintiffs.

‘Whether this finding is important to you in reaching a verdict is for you to decide.‘"

Gallo also ordered Implant Direct to pay "reasonable attorney fees in light of the degree of defendants’ culpability."

"Defendants shall reimburse plaintiff the reasonable attorneys’ fees and costs associated with (1) the time spent by plaintiffs in bringing defendants’ misconduct to the court’s attention, (2) bringing the instant motion, and (3) obtaining destroyed documents from 3rd parties," the magistrate judge wrote.

Filed Under: Dental, Legal News, News Well, Patent Infringement Tagged With: Implant Direct Manufacturing, Zest IP Holdings

In case you missed it

  • Report: Dexcom in talks to acquire Insulet
  • Henry Schein investors push back on executive pay
  • Alcon to pay $60M to acquire Kala Pharmaceuticals’ dry eye treatment
  • Creo Medical inks collaboration agreement with Intuitive
  • MedTrace Pharma moves forward on 15 O-water imaging tech
  • HistoSonics, GE Healthcare agree to integrate ultrasound into sonic beam liver therapy
  • Pfizer, BioNTech moving forward on seeking COVID-19 vaccine EUA for youngest children
  • Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
  • FDA says Philips ventilator recall produced over 21,000 device reports, 124 deaths
  • Boston Scientific’s Acurate Neo2 valve performs well in studies
  • MicroTransponder reports first commercial implantation of its stroke rehab neurostim system
  • Ambu replaces CEO with new leadership
  • Moderna’s first bivalent COVID-19 vaccine booster candidate shows promise
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
  • FDA clears Accelus’ Toro-L interbody fusion system
  • Teleflex’s UroLift cleared in China to treat BPH
  • Globus Medical announces first surgeries with Excelsius3D

RSS From Medical Design & Outsourcing

  • Henry Schein investors push back on executive pay
    Nearly half of Henry Schein (Nasdaq:HSIC) shareholders who voted at this month’s annual meeting voted against the company’s pay packages for top executives, according to a new SEC filing. About 48.5% of voting shareholders voted against the company’s executive pay plan in what’s known as the Say-on-Pay vote, according to vote results of the May… […]
  • Creo Medical inks collaboration agreement with Intuitive
    Creo Medical Group (LON: CREO) announced today that it has signed a multi-year collaboration agreement with Intuitive to make certain Creo surgical technologies compatible with the surgical robotic giant’s systems. The London exchange reacted by sending CREO shares up more than 4% to 100 pence apiece by the close of trading today. As of midday… […]
  • MedTrace Pharma moves forward on 15 O-water imaging tech
    MedTrace Pharma announced the first person scanned in its Rapid-Water-Flow Phase 3 clinical trial, further testing its tech to bring 15 O-water to imaging. The first subject scan took place at Aarhus University Hospital in Denmark, using 15 O-water produced, dosed and injected through MedTrace’s P3 automated delivery system. The clinical trial aims to evaluate… […]
  • Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
    An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting. About 54% of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday. In 2021, nearly 93%… […]
  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]
  • Ambu replaces CEO with new leadership
    Ambu today said it has hired board member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez, effective tomorrow. “Since Juan Jose Gonzalez joined as CEO in 2019, Ambu has made good progress and achieved important milestones on the strategic transformation into the world’s largest single-use endoscopy company,” Ambu Chair Jørgen Jensen said in a… […]
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
    AdvaMed executive Abby Pratt has joined the executive committee for the Biden administration’s Joint Supply Chain Resilience Working Group, the medtech industry association said today. The working group’s members from government and industry will assist with implementation of the National Strategy for a Resilient Public Health Supply Chain. Pratt oversees supply chain issues as SVP… […]
  • Toray develops new stretchable film for medical devices
    Toray Industries has a new stretchable film based on its proprietary polymer Reactis technology, with potential applications that include robotics and biological and industrial sensors. Tokyo-based Toray said it shipped samples to customers and plans research and development efforts to commercialize the new grade of film. “Recent years have increased the potential for developing stretchable… […]
  • Google Health hires FDA’s chief digital health officer
    Former FDA Chief Digital Health Officer of Global Strategy and Innovation Bakul Patel has started a new job with Google after 13 years with the regulatory agency. Patel became senior director, global digital health strategy and regulatory for Google Health earlier this month, he said on LinkedIn. Patel recounted highlights of his “incredible journey since… […]
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
    Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body. What remains to be seen is how the virus — and perhaps more importantly, our immune system’s response to it — will affect the health of people long after infection,… […]
  • FDA moves forward with Voluntary Improvement Program to bolster medical device quality
    Kathryn Burke, Emergo Group The U.S. Food and Drug Administration has issued new draft guidance to establish a full-blown voluntary program for improving quality-related processes in medical device manufacturing following promising results of a pilot program. The FDA guidance stems from a pilot undertaken by the agency along with the Medical Device Innovation Consortium (MDIC) in 2018.… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS